Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Reddit Inc (RDDT) Price & Performance

Heron Therapeutics IncTrade
Reddit IncTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Reddit Inc — how do they compare? Heron Therapeutics Inc trades at $0.47 (market cap $91.46M), while Reddit Inc trades at $185.07 (market cap $34.97B). The key difference: Reddit Inc is far larger — about 382.4× Heron Therapeutics Inc's market cap, and Reddit Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

HRTXRDDT
Market Cap
$91.46M$34.97B
Sector
HealthMedia
52-Week High
$1.96$270.71
52-Week Low
$0.39$121.84
Enterprise Value
$189.36M$32.22B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.

Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.

Reddit Inc

Reddit (RDDT) trades at $181.67, showing modest daily gains of 0.21%. The stock faces bearish technical signals with key support at $178 and resistance at $184. Fundamentally, the company demonstrates strong profitability with 91.37% gross margins and 28.6% net income margin, though valuation ratios remain elevated with a P/E of 51.77. Recent earnings show mixed results with a Q3 2025 miss but subsequent beats, while Q2 2026 results are pending.

The investment outlook balances strong fundamental growth against high valuation and technical headwinds. Analyst consensus remains bullish with a $236.89 price target (62.96% buy ratings), but risks include competitive pressures in digital advertising and execution challenges in AI initiatives. The stock offers growth potential but requires careful monitoring of upcoming earnings and market sentiment shifts.

Returns comparison

Trailing returns across standard periods

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About Reddit Inc

Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.

Read more on RDDT